NOTCH3 p.Arg1231Cys is markedly enriched in South Asians and associated with stroke.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 09 11 2023
accepted: 19 08 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 13 9 2024
Statut: epublish

Résumé

The genetic factors of stroke in South Asians are largely unexplored. Exome-wide sequencing and association analysis (ExWAS) in 75 K Pakistanis identified NM_000435.3(NOTCH3):c.3691 C > T, encoding the missense amino acid substitution p.Arg1231Cys, enriched in South Asians (alternate allele frequency = 0.58% compared to 0.019% in Western Europeans), and associated with subcortical hemorrhagic stroke [odds ratio (OR) = 3.39, 95% confidence interval (CI) = [2.26, 5.10], p = 3.87 × 10

Identifiants

pubmed: 39271666
doi: 10.1038/s41467-024-51819-3
pii: 10.1038/s41467-024-51819-3
doi:

Substances chimiques

Receptor, Notch3 0
NOTCH3 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8029

Investigateurs

Gonçalo Abecasis (G)
Adolfo Ferrando (A)
Michael Cantor (M)
Andrew Deubler (A)
John D Overton (JD)
Katherine Siminovitch (K)
Jason Portnoy (J)
Marcus B Jones (MB)
Lyndon Mitnaul (L)
Alison Fenney (A)
Manuel Allen Revez Ferreira (MAR)
Maya Ghoussaini (M)
Mona Nafde (M)
William Salerno (W)
Christina Beechert (C)
Erin D Brian (ED)
Laura M Cremona (LM)
Hang Du (H)
Caitlin Forsythe (C)
Zhenhua Gu (Z)
Kristy Guevara (K)
Michael Lattari (M)
Alexander Lopez (A)
Kia Manoochehri (K)
Prathyusha Challa (P)
Manasi Pradhan (M)
Raymond Reynoso (R)
Ricardo Schiavo (R)
Maria Sotiropoulos Padilla (MS)
Chenggu Wang (C)
Sarah E Wolf (SE)
Amelia Averitt (A)
Dadong Li (D)
Sameer Malhotra (S)
Justin Mower (J)
Mudasar Sarwar (M)
Sean Yu (S)
Xingmin Aaron Zhang (XA)
Muhammad Aqeel (M)
Manan Goyal (M)
George Mitra (G)
Sanjay Sreeram (S)
Rouel Lanche (R)
Vrushali Mahajan (V)
Sai Lakshmi Vasireddy (SL)
Gisu Eom (G)
Krishna Pawan Punuru (KP)
Sujit Gokhale (S)
Benjamin Sultan (B)
Pooja Mule (P)
Eliot Austin (E)
Xiaodong Bai (X)
Lance Zhang (L)
Sean O'Keeffe (S)
Razvan Panea (R)
Evan Edelstein (E)
Ayesha Rasool (A)
Evan K Maxwell (EK)
Boris Boutkov (B)
Alexander Gorovits (A)
Ju Guan (J)
Lukas Habegger (L)
Alicia Hawes (A)
Olga Krasheninina (O)
Samantha Zarate (S)
Adam J Mansfield (AJ)
Kathy Burch (K)
Adrian Campos (A)
Liron Ganel (L)
Sheila Gaynor (S)
Benjamin Geraghty (B)
Arkopravo Ghosh (A)
Salvador Romero Martinez (SR)
Christopher Gillies (C)
Lauren Gurski (L)
Joseph Herman (J)
Eric Jorgenson (E)
Tyler Joseph (T)
Michael Kessler (M)
Jack Kosmicki (J)
Adam Locke (A)
Priyanka Nakka (P)
Karl Landheer (K)
Olivier Delaneau (O)
Anthony Marcketta (A)
Joelle Mbatchou (J)
Arden Moscati (A)
Aditeya Pandey (A)
Anita Pandit (A)
Jonathan Ross (J)
Carlo Sidore (C)
Eli Stahl (E)
Timothy Thornton (T)
Peter VandeHaar (P)
Sailaja Vedantam (S)
Rujin Wang (R)
Kuan-Han Wu (KH)
None Bin Ye
Blair Zhang (B)
Andrey Ziyatdinov (A)
Yuxin Zou (Y)
Jingning Zhang (J)
Kyoko Watanabe (K)
Mira Tang (M)
Frank Wendt (F)
Suganthi Balasubramanian (S)
Suying Bao (S)
Kathie Sun (K)
Chuanyi Zhang (C)
Brian Hobbs (B)
Jon Silver (J)
William Palmer (W)
Rita Guerreiro (R)
Amit Joshi (A)
Antoine Baldassari (A)
Cristen Willer (C)
Sarah Graham (S)
Ernst Mayerhofer (E)
Mary Haas (M)
George Hindy (G)
Jonas Bovijn (J)
Parsa Akbari (P)
Luanluan Sun (L)
Olukayode Sosina (O)
Arthur Gilly (A)
Peter Dornbos (P)
Moeen Riaz (M)
Momodou W Jallow (MW)
Anna Alkelai (A)
Ariane Ayer (A)
Veera Rajagopal (V)
Vijay Kumar (V)
Jacqueline Otto (J)
Aysegul Guvenek (A)
Jose Bras (J)
Silvia Alvarez (S)
Jessie Brown (J)
Jing He (J)
Hossein Khiabanian (H)
Joana Revez (J)
Kimberly Skead (K)
Valentina Zavala (V)
Jae Soon Sul (JS)
Lei Chen (L)
Sam Choi (S)
Amy Damask (A)
Nan Lin (N)
Charles Paulding (C)
Esteban Chen (E)
Michelle G LeBlanc (MG)
Jason Mighty (J)
Jennifer Rico-Varela (J)
Nirupama Nishtala (N)
Nadia Rana (N)
Jaimee Hernandez (J)
Randi Schwartz (R)
Jody Hankins (J)
Anna Han (A)
Samuel Hart (S)
Ann Perez-Beals (A)
Gina Solari (G)
Johannie Rivera-Picart (J)
Michelle Pagan (M)
Sunilbe Siceron (S)

Informations de copyright

© 2024. The Author(s).

Références

Mills, M. C. & Rahal, C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat. Genet 52, 242–243 (2020).
pubmed: 32139905 doi: 10.1038/s41588-020-0580-y
Collaborators, G. B. D. S. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20, 795–820 (2021).
doi: 10.1016/S1474-4422(21)00252-0
Sherin, A. et al. Prevalence of stroke in Pakistan: findings from Khyber Pakhtunkhwa integrated population health survey (KP-IPHS) 2016-17. Pak. J. Med. Sci. 36, 1435–1440 (2020).
pubmed: 33235553 pmcid: 7674892 doi: 10.12669/pjms.36.7.2824
Valcarcel-Nazco, C. et al. Variability in the use of neuroimaging techniques for diagnosis and follow-up of stroke patients. Neurologia (Engl. Ed.) 34, 360–366 (2019).
pubmed: 28431835
Farooq, A., Venketasubramanian, N. & Wasay, M. Stroke care in Pakistan. Cerebrovasc. Dis. Extra 11, 118–121 (2021).
pubmed: 34695824 pmcid: 8613565 doi: 10.1159/000519554
Farooq, M. U., Majid, A., Reeves, M. J. & Birbeck, G. L. The epidemiology of stroke in Pakistan: past, present, and future. Int. J. Stroke 4, 381–389 (2009).
pubmed: 19765127 doi: 10.1111/j.1747-4949.2009.00327.x
Mullen, M. T. et al. Hospital-level variability in reporting of ischemic stroke subtypes and supporting diagnostic evaluation in GWTG-stroke registry. J. Am. Heart Assoc. 12, e031303 (2023).
pubmed: 38108258 pmcid: 10863791 doi: 10.1161/JAHA.123.031303
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E. & Bousser, M. G. Cadasil. Lancet Neurol. 8, 643–653 (2009).
pubmed: 19539236 doi: 10.1016/S1474-4422(09)70127-9
Markidan, J. et al. Smoking and risk of ischemic stroke in young men. Stroke 49, 1276–1278 (2018).
pubmed: 29674522 pmcid: 5916531 doi: 10.1161/STROKEAHA.117.018859
Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115–123 (2022).
pubmed: 36180795 pmcid: 9524349 doi: 10.1038/s41586-022-05165-3
Scott, E. M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat. Genet 48, 1071–1076 (2016).
pubmed: 27428751 pmcid: 5019950 doi: 10.1038/ng.3592
Wang, T., Baron, M. & Trump, D. An overview of Notch3 function in vascular smooth muscle cells. Prog. Biophys. Mol. Biol. 96, 499–509 (2008).
pubmed: 17854869 doi: 10.1016/j.pbiomolbio.2007.07.006
Duvaud, S. et al. Expasy, the Swiss Bioinformatics Resource Portal, as designed by its users. Nucleic Acids Res. 49, W216–w227 (2021).
pubmed: 33849055 pmcid: 8265094 doi: 10.1093/nar/gkab225
Rutten, J. W. et al. Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. Neurology 95, e1835–e1843 (2020).
pubmed: 32732295 pmcid: 7682826 doi: 10.1212/WNL.0000000000010525
Rodriguez-Flores, J. L. et al. The QChip1 knowledgebase and microarray for precision medicine in Qatar. NPJ Genom. Med. 7, 3 (2022).
pubmed: 35046417 pmcid: 8770564 doi: 10.1038/s41525-021-00270-0
Hoffmann, T. J. et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet 49, 54–64 (2017).
pubmed: 27841878 doi: 10.1038/ng.3715
Hack, R. J. et al. Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction. Brain 146, 2913–2927 (2023).
pubmed: 36535904 doi: 10.1093/brain/awac486
Cho, B. P. H. et al. Association of vascular risk factors and genetic factors with penetrance of variants causing monogenic stroke. JAMA Neurol. 79, 1303–1311 (2022).
pubmed: 36300346 pmcid: 9614680 doi: 10.1001/jamaneurol.2022.3832
Rutten, J. W. et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant. Genet Med. 21, 676–682 (2019).
pubmed: 30032161 doi: 10.1038/s41436-018-0088-3
Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42, D980-985 (2014).
Rutten, J. W. et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann. Clin. Transl. Neurol. 3, 844–853 (2016).
pubmed: 27844030 pmcid: 5099530 doi: 10.1002/acn3.344
Rutten, J. W. et al. Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept. Brain 139, 1123–1135 (2016).
pubmed: 26912635 doi: 10.1093/brain/aww011
Gravesteijn, G. et al. Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients. Hum. Mol. Genet 29, 1853–1863 (2020).
pubmed: 31960911 pmcid: 7372551 doi: 10.1093/hmg/ddz285
Ghezali, L. et al. Notch3(ECD) immunotherapy improves cerebrovascular responses in CADASIL mice. Ann. Neurol. 84, 246–259 (2018).
pubmed: 30014602 doi: 10.1002/ana.25284
Belin de Chantemele, E. J. et al. Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb. Vasc. Biol. 28, 2216–2224 (2008).
pubmed: 18818417 doi: 10.1161/ATVBAHA.108.171751
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet 53, 1097–1103 (2021).
pubmed: 34017140 doi: 10.1038/s41588-021-00870-7
Greenland, S. in Modern epidemiology, 3rd edn 295–297 (Lippincott Williams & Wilkins, 2008).
Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628–634 (2021).
pubmed: 34662886 pmcid: 8596853 doi: 10.1038/s41586-021-04103-z
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B (Methodol.) 57, 289–300 (1995).
doi: 10.1111/j.2517-6161.1995.tb02031.x
Elliott, L. T. et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature 562, 210–216 (2018).
pubmed: 30305740 pmcid: 6786974 doi: 10.1038/s41586-018-0571-7
Griffanti, L. et al. BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities. Neuroimage 141, 191–205 (2016).
pubmed: 27402600 doi: 10.1016/j.neuroimage.2016.07.018
Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993).
pubmed: 7678184 doi: 10.1161/01.STR.24.1.35
Bamford, J., Sandercock, P., Dennis, M., Burn, J. & Warlow, C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337, 1521–1526 (1991).
pubmed: 1675378 doi: 10.1016/0140-6736(91)93206-O
Saleheen, D. et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature 544, 235–239 (2017).
pubmed: 28406212 pmcid: 5600291 doi: 10.1038/nature22034
Krasheninina, O. et al. Open-source mapping and variant calling for large-scale NGS data from original base-quality scores. Biorxiv https://doi.org/10.1101/2020.12.15.356360 (2020).
Lin, M., Park, D. S., Zaitlen, N. A., Henn, B. M. & Gignoux, C. R. Admixed populations improve power for variant discovery and portability in genome-wide association studies. Front Genet 12, 673167 (2021).
pubmed: 34108994 pmcid: 8181458 doi: 10.3389/fgene.2021.673167
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
pubmed: 32461654 pmcid: 7334197 doi: 10.1038/s41586-020-2308-7
Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Mills, R. E. et al. An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res. 16, 1182–1190 (2006).
pubmed: 16902084 pmcid: 1557762 doi: 10.1101/gr.4565806
Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452–W457 (2012).
pubmed: 22689647 pmcid: 3394338 doi: 10.1093/nar/gks539
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet Chapter 7, Unit7 20 (2013).
Chun, S. & Fay, J. C. Identification of deleterious mutations within three human genomes. Genome Res. 19, 1553–1561 (2009).
pubmed: 19602639 pmcid: 2752137 doi: 10.1101/gr.092619.109
Steinhaus, R. et al. MutationTaster2021. Nucleic Acids Res. 49, W446–W451 (2021).
pubmed: 33893808 pmcid: 8262698 doi: 10.1093/nar/gkab266
Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 103 (2020).
pubmed: 33261662 pmcid: 7709417 doi: 10.1186/s13073-020-00803-9
Skol, A. D., Scott, L. J., Abecasis, G. R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet 38, 209–213 (2006).
pubmed: 16415888 doi: 10.1038/ng1706
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet 38, 904–909 (2006).
pubmed: 16862161 doi: 10.1038/ng1847
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https://doi.org/10.1038/nbt.4314 (2018).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Efron, B. & Tibshirani, R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat. Sci. 1, 54–75 (1986).
Joutel, A. et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J. Clin. Invest 120, 433–445 (2010).
pubmed: 20071773 pmcid: 2810078 doi: 10.1172/JCI39733

Auteurs

Juan Lorenzo Rodriguez-Flores (JL)

Regeneron Genetics Center, Tarrytown, NY, USA.

Shareef Khalid (S)

Columbia University, New York, NY, USA.
Center for Non-Communicable Diseases, Karachi, Pakistan.

Neelroop Parikshak (N)

Regeneron Genetics Center, Tarrytown, NY, USA.

Asif Rasheed (A)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Bin Ye (B)

Regeneron Genetics Center, Tarrytown, NY, USA.

Manav Kapoor (M)

Regeneron Genetics Center, Tarrytown, NY, USA.

Joshua Backman (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

Farshid Sepehrband (F)

Regeneron Genetics Center, Tarrytown, NY, USA.

Silvio Alessandro Di Gioia (SAD)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Sahar Gelfman (S)

Regeneron Genetics Center, Tarrytown, NY, USA.

Tanima De (T)

Regeneron Genetics Center, Tarrytown, NY, USA.

Nilanjana Banerjee (N)

Regeneron Genetics Center, Tarrytown, NY, USA.

Deepika Sharma (D)

Regeneron Genetics Center, Tarrytown, NY, USA.

Hector Martinez (H)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Sofia Castaneda (S)

Rye Country Day School, Rye, NY, USA.

David D'Ambrosio (D)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Xingmin A Zhang (XA)

Regeneron Genetics Center, Tarrytown, NY, USA.

Pengcheng Xun (P)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Ellen Tsai (E)

University of California at Los Angeles, Los Angeles, CA, USA.

I-Chun Tsai (IC)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Maleeha Zaman Khan (MZ)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Muhammad Jahanzaib (M)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Muhammad Rehan Mian (MR)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Muhammad Bilal Liaqat (MB)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Khalid Mahmood (K)

Dow University of Health Sciences and Civil Hospital, Karachi, Pakistan.

Tanvir Us Salam (TU)

Lahore General Hospital, Lahore, Pakistan.

Muhammad Hussain (M)

Lahore General Hospital, Lahore, Pakistan.

Javed Iqbal (J)

Department of Neurology, Allied Hospital, Faisalabad, Pakistan.

Faizan Aslam (F)

Department of Neurology, Aziz Fatima Hospital, Faisalabad, Pakistan.

Michael N Cantor (MN)

Regeneron Genetics Center, Tarrytown, NY, USA.

Gannie Tzoneva (G)

Regeneron Genetics Center, Tarrytown, NY, USA.

John Overton (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jonathan Marchini (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jeffrey G Reid (JG)

Regeneron Genetics Center, Tarrytown, NY, USA.

Aris Baras (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Niek Verweij (N)

Regeneron Genetics Center, Tarrytown, NY, USA.

Luca A Lotta (LA)

Regeneron Genetics Center, Tarrytown, NY, USA.

Giovanni Coppola (G)

Regeneron Genetics Center, Tarrytown, NY, USA.

Katia Karalis (K)

Regeneron Genetics Center, Tarrytown, NY, USA.

Aris Economides (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Sergio Fazio (S)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Wolfgang Liedtke (W)

Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

John Danesh (J)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Ayeesha Kamal (A)

Section of Neurology, Department of Medicine, Aga Khan University, Karachi, Pakistan.

Philippe Frossard (P)

Center for Non-Communicable Diseases, Karachi, Pakistan.

Thomas Coleman (T)

Regeneron Genetics Center, Tarrytown, NY, USA.

Alan R Shuldiner (AR)

Regeneron Genetics Center, Tarrytown, NY, USA. alan.shuldiner@regeneron.com.

Danish Saleheen (D)

Columbia University, New York, NY, USA. danish.saleheen@cncdpk.com.
Center for Non-Communicable Diseases, Karachi, Pakistan. danish.saleheen@cncdpk.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH